Home » BIOPHAN ANNOUNCES ACCELERATION OF COMMERCIALIZATION OF MYO-VAD CARDIAC ASSIST DEVICE
BIOPHAN ANNOUNCES ACCELERATION OF COMMERCIALIZATION OF MYO-VAD CARDIAC ASSIST DEVICE
Biophan Technologies, Inc., a developer of next-generation biomedical technology, today announced the acceleration of the commercialization program of the MYO-VAD following the recently announced agreement for its acquisition and investment in MYOTECH, LLC. Under the terms of the purchase agreement, Biophan will acquire a minority interest of roughly 40 percent of MYOTECH in exchange for issuing approximately 4.9 million shares of Biophan common stock and a cash payment of $2.225 million over time.
Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=1122395XSL_NEWSML_TO_NEWSML_WEB.xml)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May